AlbionVC Publication

Venture capital firm investing from late seed to Series B in B2B software, deeptech and healthcare in the UK.

Christoph Ruedig in AlbionVC Publication

Sep 9, 2021

HealthTech primer for Europe: Our thoughts on the state and future of technology in European healthcare

Christoph Ruedig in AlbionVC Publication

Aug 31, 2021

Our journey with Oviva: seed to Series C

Today, AlbionVC portfolio company Oviva announced that they raised $80m in a Series C…

Paul Lehair in AlbionVC Publication

Jul 22, 2021

Why we invested in Gravitee.io

We are delighted to announce that we have co-led an $11m series A round in Gravitee.io, an exciting open…

AlbionVC in AlbionVC Publication

Jun 29, 2021

A masterclass in media relations: how to get press for your startup

1 response

Jane Elizabeth Reddin in AlbionVC Publication

Jun 24, 2021

Want to make your company more investable?

Hiring well is more than a catalyst for growth. It’s a foundational capability which…

Jessica Bartos in AlbionVC Publication

Jun 22, 2021

Why we invested in NuvoAir

The Covid-19 pandemic provides a unique opportunity to reshape healthcare delivery as we know it. As health…

Jay Wilson in AlbionVC Publication

May 25, 2021

Why we invested in Accelex | AlbionVC

Every quarter we embark on a portfolio valuation exercise which entails haranguing the CFOs…

Cat McDonald in AlbionVC Publication

May 18, 2021

Why we are doubling down on Healios!

AlbionVC has been investing in healthcare services for 20 years and in digital health for more…

Jane Elizabeth Reddin in AlbionVC Publication

Apr 22, 2021

The Trust Index: How Series A founders can develop a cohesive team

AlbionVC in AlbionVC Publication

Feb 22, 2021

Why you should consider manufacturing from the start of the biotech R&D process

About

AlbionVC Publication

Venture capital firm investing from late seed to Series B in B2B software, deeptech and healthcare in the UK.

More information

Followers

Elsewhere